Autifony Therapeutics Ltd, a 2011 spin-out from GlaxoSmithKline Plc with technology to treat hearing disorders, has received £2.2 million in grant funding from UK Technology Strategy Board. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
